Cargando…
Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS
BACKGROUND: Clear cell sarcoma (CCS) is a therapeutically unresolved, aggressive, soft tissue sarcoma (STS) that predominantly affects young adults. This sarcoma is defined by t(12;22)(q13;q12) translocation, which leads to the fusion of Ewing sarcoma gene (EWS) to activating transcription factor 1...
Autores principales: | Outani, Hidetatsu, Tanaka, Takaaki, Wakamatsu, Toru, Imura, Yoshinori, Hamada, Kenichiro, Araki, Nobuhito, Itoh, Kazuyuki, Yoshikawa, Hideki, Naka, Norifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076438/ https://www.ncbi.nlm.nih.gov/pubmed/24946937 http://dx.doi.org/10.1186/1471-2407-14-455 |
Ejemplares similares
-
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
por: Nakai, Takaaki, et al.
Publicado: (2017) -
Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016) -
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2014) -
CCS
por: Stickland, D P
Publicado: (2004) -
Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
por: Yamada, Shutaro, et al.
Publicado: (2017)